BLCM - Bellicum Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

with an average potential upside of $129.64 (96.61%) from yesterday's end of day stock price of $0.2. Bellicum Pharmaceuticals activity chart has currently 19 price targets and 17 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.86% with an average time for these price targets to be met of 25.8 days.

Most recent stock forecast was given by WANGZHI LI from LADENBURG on 30-Oct-2020. First documented stock forecast 09-Aug-2016.

Best performing analysts who are covering BLCM - Bellicum Pharmaceuticals:

Jim Birchenough Biren Amin Josh Schimmer Wangzhi Li Elemer Piros

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

3 years 1 months 10 days ago

0/2 (0%)

$200.1 (182.07%)

4.5

$4.3 (2150.00%)

4

3 years 1 months 11 days ago

4/4 (100%)

$-1.4 (-23.73%)

35

Buy

180

$179.67 (54445.45%)

100

5 years 7 months 28 days ago

0/4 (0%)

$127.35 (110.01%)

Buy

160

$159.8 (79900.00%)

160

5 years 8 months 26 days ago

1/7 (14.29%)

$77.8 (94.65%)

94

Buy

450

$448.97 (43589.32%)

450

7 years 11 months 22 days ago

0/3 (0%)

$244.37 (120.06%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BLCM (Bellicum Pharmaceuticals) average time for price targets to be met?

On average it took 25.8 days on average for the stock forecasts to be realized with a an average price target met ratio 22.86

Which analyst has the current highest performing score on BLCM (Bellicum Pharmaceuticals) with a proven track record?

JIM BIRCHENOUGH

Which analyst has the current lower performing score on BLCM (Bellicum Pharmaceuticals) with a proven track record?

ELEMER PIROS

Which analyst has the most public recommendations on BLCM (Bellicum Pharmaceuticals)?

Jim Birchenough works at WELLS FARGO and has 6 price targets and 4 ratings on BLCM

Which analyst is the currently most bullish on BLCM (Bellicum Pharmaceuticals)?

Joshua Schimmer with highest potential upside - $448.97

Which analyst is the currently most reserved on BLCM (Bellicum Pharmaceuticals)?

Wangzhi Li with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart